Cardiovascular disease in women: Clinical perspectives

Circulation Research

Volumn 118, Issue 8, 2016, Pages 1273-1293

  Garcia, Mariana ^a   Mulvagh, Sharon L ^a   Merz, C Noel Bairey ^b   Buring, Julie E ^c,d   Manson, JoAnn E ^c,d  

^a MAYO CLINIC   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

acute coronary syndromes; cardiovascular disease; primary prevention; risk factors; women

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTA ANEURYSM; ACUTE CORONARY SYNDROME; AUTOIMMUNE DISEASE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CORONARY ARTERY; CORONARY ARTERY DISSECTION; DEPRESSION; DIABETES MELLITUS; DYSLIPIDEMIA; HEALTH; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART INFARCTION; HEART REHABILITATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MATERNAL HYPERTENSION; MENOPAUSE; OBESITY; PERIPARTUM CARDIOMYOPATHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL INACTIVITY; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SALPINGOOOPHORECTOMY; SEX DIFFERENCE; SMOKING; SPONTANEOUS CORONARY ARTERY DISSECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TAKOTSUBO CARDIOMYOPATHY; UNITED STATES; WEIGHT GAIN; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; FEMALE; PREVENTION AND CONTROL; RISK FACTOR; RISK REDUCTION; TRENDS; WOMEN'S HEALTH;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; OBESITY; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING; WOMEN'S HEALTH;

EID: 84963799420     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.307547     Document Type: Review

References (218)

1. Mozaffarian D, Benjamin EJ, Go AS, American Heart Association Statistics Committee and Stroke Statistics Subcommittee American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015 131 e29 322. doi: 10.1161/CIR.0000000000000152
2. Wilmot KA, O'Flaherty M, Capewell S, Ford ES, Vaccarino V, Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011: Evidence for Stagnation in Young Adults, Especially Women. Circulation 2015 132 997 1002. doi: 10.1161/CIRCULATIONAHA.115.015293
3. Mosca L, Mochari-Greenberger H, Dolor RJ, Newby LK, Robb KJ, Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes 2010 3 120 127. doi: 10.1161/CIRCOUTCOMES.109.915538
4. Abuful A, Gidron Y, Henkin Y, Physicians' attitudes toward preventive therapy for coronary artery disease: is there a gender bias? Clin Cardiol 2005 28 389 393
5. Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, Fabunmi RP, Kwan J, Mills T, Simpson SL, National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005 111 499 510. doi: 10.1161/01.CIR.0000154568.43333.82
6. Gu Q, Burt VL, Paulose-Ram R, Dillon CF, Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004. Am J Hypertens 2008 21 789 798. doi: 10.1038/ajh.2008.185
7. Bird CE, Fremont AM, Bierman AS, Wickstrom S, Shah M, Rector T, Horstman T, Escarce JJ, Does quality of care for cardiovascular disease and diabetes differ by gender for enrollees in managed care plans? Womens Health Issues 2007 17 131 138. doi: 10.1016/j.whi.2007.03.001
8. Chou AF, Scholle SH, Weisman CS, Bierman AS, Correa-de-Araujo R, Mosca L, Gender disparities in the quality of cardiovascular disease care in private managed care plans. Womens Health Issues 2007 17 120 130. doi: 10.1016/j.whi.2007.03.002
9. Witt BJ, Jacobsen SJ, Weston SA, Killian JM, Meverden RA, Allison TG, Reeder GS, Roger VL, Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol 2004 44 988 996. doi: 10.1016/j.jacc.2004.05.062
10. Suaya JA, Shepard DS, Normand SL, Ades PA, Prottas J, Stason WB, Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation 2007 116 1653 1662. doi: 10.1161/CIRCULATIONAHA.107.701466
11. Thomas RJ, Miller NH, Lamendola C, Berra K, Hedbäck B, Durstine JL, Haskell W, National survey on gender differences in cardiac rehabilitation programs. Patient characteristics and enrollment patterns. J Cardiopulm Rehabil 1996 16 402 412
12. Ghisi GL, Polyzotis P, Oh P, Pakosh M, Grace SL, Physician factors affecting cardiac rehabilitation referral and patient enrollment: a systematic review. Clin Cardiol 2013 36 323 335. doi: 10.1002/clc.22126
13. Smilowitz NR, Sampson BA, Abrecht CR, Siegfried JS, Hochman JS, Reynolds HR, Women have less severe and extensive coronary atherosclerosis in fatal cases of ischemic heart disease: an autopsy study. Am Heart J 2011 161 681 688. doi: 10.1016/j.ahj.2010.12.022
14. Moriel M, Rozanski A, Klein J, Berman DS, Merz CN, The limited efficacy of exercise radionuclide ventriculography in assessing prognosis of women with coronary artery disease. Am J Cardiol 1995 76 1030 1035
15. Shaw LJ, Bairey Merz CN, Pepine CJ, WISE Investigators WISE Investigators Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006 47 S4 S20. doi: 10.1016/j.jacc.2005.01.072
16. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyumi AA, Sopko G, WISE Investigators WISE Investigators Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006 47 S21 S29. doi: 10.1016/j.jacc.2004.12.084
17. Shaw LJ, Shaw RE, Merz CN, Brindis RG, Klein LW, Nallamothu B, Douglas PS, Krone RJ, McKay CR, Block PC, Hewitt K, Weintraub WS, Peterson ED, American College of Cardiology-National Cardiovascular Data Registry Investigators American College of Cardiology-National Cardiovascular Data Registry Investigators Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation 2008 117 1787 1801. doi: 10.1161/CIRCULATIONAHA.107.726562
18. Von Mering GO, Arant CB, Wessel TR, McGorray SP, Bairey Merz CN, Sharaf BL, Smith KM, Olson MB, Johnson BD, Sopko G, Handberg E, Pepine CJ, Kerensky RA, National Heart, Lung, and Blood Institute National Heart, Lung, and Blood Institute Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004 109 722 725. doi: 10.1161/01.CIR.0000115525.92645.16
19. Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Tielsch JM, Klein BE, Hubbard LD, Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA 2002 287 1153 1159
20. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R, Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 1998 97 2110 2116
21. Reynolds HR, Srichai MB, Iqbal SN, Slater JN, Mancini GB, Feit F, Pena-Sing I, Axel L, Attubato MJ, Yatskar L, Kalhorn RT, Wood DA, Lobach IV, Hochman JS, Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation 2011 124 1414 1425. doi: 10.1161/CIRCULATIONAHA.111.026542
22. Daly C, Clemens F, Lopez Sendon JL, Tavazzi L, Boersma E, Danchin N, Delahaye F, Gitt A, Julian D, Mulcahy D, Ruzyllo W, Thygesen K, Verheugt F, Fox KM, Euro Heart Survey Investigators Euro Heart Survey Investigators Gender differences in the management and clinical outcome of stable angina. Circulation 2006 113 490 498. doi: 10.1161/CIRCULATIONAHA.105.561647
23. Vaccarino V, Parsons L, Peterson ED, Rogers WJ, Kiefe CI, Canto J, Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006. Arch Intern Med 2009 169 1767 1774. doi: 10.1001/archinternmed.2009.332
24. Jneid H, Fonarow GC, Cannon CP, Hernandez AF, Palacios IF, Maree AO, Wells Q, Bozkurt B, Labresh KA, Liang L, Hong Y, Newby LK, Fletcher G, Peterson E, Wexler L, Get With the Guidelines Steering Committee and Investigators Get With the Guidelines Steering Committee and Investigators Sex differences in medical care and early death after acute myocardial infarction. Circulation 2008 118 2803 2810. doi: 10.1161/CIRCULATIONAHA.108.789800
25. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K, Diercks DB, Brogan GX Jr, Boden WE, Roe MT, Ohman EM, Gibler WB, Newby LK, CRUSADE Investigators CRUSADE Investigators Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 2005 45 832 837. doi: 10.1016/j.jacc.2004.11.055
26. Center for Disease Control and Prevention. National Diabetes Statistics Report. Estimates of Diabetes and Its Burden in the United States, 2014 2014 Atlanta, GA U.S Department of Health and Human Services
27. Roger VL, Go AS, Lloyd-Jones DM, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011 123 e18 e209. doi: 10.1161/CIR.0b013e3182009701
28. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL, Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991 265 627 631
29. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, Arky RA, Speizer FE, Hennekens CH, A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991 151 1141 1147
30. Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M, Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004 27 2898 2904
31. Huxley R, Barzi F, Woodward M, Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006 332 73 78. doi: 10.1136/bmj.38678.389583.7C
32. Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, Baron AD, Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 2000 101 2040 2046
33. Carr ME, Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 2001 15 44 54
34. Pradhan AD, Sex differences in the metabolic syndrome: implications for cardiovascular health in women. Clin Chem 2014 60 44 52. doi: 10.1373/clinchem.2013.202549
35. Haffner SM, Miettinen H, Stern MP, Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men. Diabetologia 1997 40 711 717. doi: 10.1007/s001250050738
36. Donahue RP, Rejman K, Rafalson LB, Dmochowski J, Stranges S, Trevisan M, Sex differences in endothelial function markers before conversion to pre-diabetes: does the clock start ticking earlier among women? The Western New York Study. Diabetes Care 2007 30 354 359. doi: 10.2337/dc06-1772
37. Current Cigarette Smoking Among U.S. Adults Aged 18 Years and Older 2012
38. Huxley RR, Woodward M, Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011 378 1297 1305. doi: 10.1016/S0140-6736(11)60781-2
39. Lidegaard O, Smoking and use of oral contraceptives: impact on thrombotic diseases. Am J Obstet Gynecol 1999 180 S357 S363
40. Pomp ER, Rosendaal FR, Doggen CJ, Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol 2008 83 97 102. doi: 10.1002/ajh.21059
41. Flegal KM, Carroll MD, Ogden CL, Johnson CL, Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002 288 1723 1727
42. Flegal KM, Carroll MD, Ogden CL, Curtin LR, Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010 303 235 241. doi: 10.1001/jama.2009.2014
43. Fitzgerald KR, Review of article: prevalence of obesity and trends in the distribution of body mass index among us adults, 1999-2010 by Katherine M. Flegal, PhD; Margaret D. Carroll, MSPH; Brian K. Kit, MD; Cynthia L. Ogden, PhD (JAMA 2012;307:491-7). J Vasc Nurs 2013 31 131 132. doi: 10.1016/j.jvn.2013.06.004
44. Ogden CL, Carroll MD, Kit BK, Flegal KM, Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014 311 806 814. doi: 10.1001/jama.2014.732
45. Flegal KM, Carroll MD, Kit BK, Ogden CL, Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012 307 491 497. doi: 10.1001/jama.2012.39
46. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB, Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002 162 1867 1872
47. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB, Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999 159 1104 1109
48. Go AS, Mozaffarian D, Roger VL, American Heart Association Statistics Committee and Stroke Statistics Subcommittee American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013 127 e6 e245. doi: 10.1161/CIR.0b013e31828124ad
49. Schiller JS LJ, Ward BW, Peregoy JA, Summary Health Statistics for US Adults: National Health Interview Survey, 2010 2012
50. Sattelmair J, Pertman J, Ding EL, Kohl HW III, Haskell W, Lee IM, Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation 2011 124 789 795. doi: 10.1161/CIRCULATIONAHA.110.010710
51. Shiroma EJ, Lee IM, Physical activity and cardiovascular health: lessons learned from epidemiological studies across age, gender, and race/ethnicity. Circulation 2010 122 743 752. doi: 10.1161/CIRCULATIONAHA.109.914721
52. Giralt D, Domingues-Montanari S, Mendioroz M, Ortega L, Maisterra O, Perea-Gainza M, Delgado P, Rosell A, Montaner J, The gender gap in stroke: a meta-analysis. Acta Neurol Scand 2012 125 83 90. doi: 10.1111/j.1600-0404.2011.01514.x
53. Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, Franconi F, Gerdts E, Foryst-Ludwig A, Maas AH, Kautzky-Willer A, Knappe-Wegner D, Kintscher U, Ladwig KH, Schenck-Gustafsson K, Stangl V, Gender in cardiovascular diseases: Impact on clinical manifestations, management, and outcomes. Eur Heart J 2016 37 24 34
54. Lloyd-Jones DM, Evans JC, Levy D, Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 2005 294 466 472. doi: 10.1001/jama.294.4.466
55. James PA, Oparil S, Carter BL, 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014 311 507 520. doi: 10.1001/jama.2013.284427
56. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT, A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015 373 2103 2116
57. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 364 937 952. doi: 10.1016/S0140-6736(04)17018-9
58. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr, Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998 279 1615 1622
59. Pedersen TR, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Faergeman G, Pyörälä K, Miettinen T, Wilhelmsen L, Olsson AG, Wedel H, Scandinavian Simvastatin Survival Study Group Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler Suppl 2004 5 81 87. doi: 10.1016/j.atherosclerosissup.2004.08.027
60. Stone NJ, Robinson JG, Lichtenstein AH, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 129 S1 S45. doi: 10.1161/01.cir.0000437738.63853.7a
61. Kavousi M, Leening MJ, Nanchen D, Greenland P, Graham IM, Steyerberg EW, Ikram MA, Stricker BH, Hofman A, Franco OH, Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA 2014 311 1416 1423. doi: 10.1001/jama.2014.2632
62. Mercado C, DeSimone AK, Odom E, Gillespie C, Ayala C, Loustalot F, Prevalence of Cholesterol Treatment Eligibility and Medication Use Among Adults-United States, 2005-2012. MMWR Morb Mortal Wkly Rep 2015 64 1305 1311. doi: 10.15585/mmwr.mm6447a1
63. Virani SS, Woodard LD, Ramsey DJ, Urech TH, Akeroyd JM, Shah T, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA, Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol 2015 115 21 26. doi: 10.1016/j.amjcard.2014.09.041
64. Safford MM, Gamboa CM, Durant RW, Brown TM, Glasser SP, Shikany JM, Zweifler RM, Howard G, Muntner P, Race-sex differences in the management of hyperlipidemia: the REasons for Geographic and Racial Differences in Stroke study. Am J Prev Med 2015 48 520 527. doi: 10.1016/j.amepre.2014.10.025
65. Parris ES, Lawrence DB, Mohn LA, Long LB, Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care 2005 28 595 599
66. Aiman U, Najmi A, Khan RA, Statin induced diabetes and its clinical implications. J Pharmacol Pharmacother 2014 5 181 185. doi: 10.4103/0976-500X.136097
67. Persson M, Hedblad B, Nelson JJ, Berglund G, Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects. Arterioscler Thromb Vasc Biol 2007 27 1411 1416. doi: 10.1161/ATVBAHA.107.142679
68. Judd SE, Fang K, Safford M, Cushman M, Abstract 19268: Robust performance of lppla2 activity in predicting cardiovascular disease risk in a national, diverse, sample. Circulation 2015 132 A19268
69. Gotsch F, Gotsch F, Romero R, Erez O, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Kim SK, Hassan S, Yeo L, The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth. J Matern Fetal Neonatal Med 2009 22 suppl 2 5 23. doi: 10.1080/14767050902860690
70. Kessous R, Shoham-Vardi I, Pariente G, Holcberg G, Sheiner E, An association between preterm delivery and long-term maternal cardiovascular morbidity. Am J Obstet Gynecol 2013 209 368.e1 368.e8. doi: 10.1016/j.ajog.2013.05.041
71. Bellamy L, Casas JP, Hingorani AD, Williams DJ, Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007 335 974. doi: 10.1136/bmj.39335.385301.BE
72. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997 20 1183 1197
73. Lawrence JM, Contreras R, Chen W, Sacks DA, Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care 2008 31 899 904. doi: 10.2337/dc07-2345
74. American Diabetes Association Classification and diagnosis of diabetes. Diabetes Care 2015 38 suppl S8 S16. doi: 10.2337/dc15-S005
75. Bellamy L, Casas JP, Hingorani AD, Williams D, Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009 373 1773 1779. doi: 10.1016/S0140-6736(09)60731-5
76. Vrachnis N, Augoulea A, Iliodromiti Z, Lambrinoudaki I, Sifakis S, Creatsas G, Previous gestational diabetes mellitus and markers of cardiovascular risk. Int J Endocrinol 2012 2012 458610. doi: 10.1155/2012/458610
77. Linné Y, Dye L, Barkeling B, Rössner S, Long-term weight development in women: a 15-year follow-up of the effects of pregnancy. Obes Res 2004 12 1166 1178. doi: 10.1038/oby.2004.146
78. Kew S, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R, Cardiometabolic implications of postpartum weight changes in the first year after delivery. Diabetes Care 2014 37 1998 2006. doi: 10.2337/dc14-0087
79. del Rincón I, Polak JF, O'Leary DH, Battafarano DF, Erikson JM, Restrepo JF, Molina E, Escalante A, Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis. Ann Rheum Dis 2015 74 1118 1123. doi: 10.1136/annrheumdis-2013-205058
80. Gianturco L, Bodini BD, Atzeni F, Colombo C, Stella D, Sarzi-Puttini P, Drago L, Galaverna S, Turiel M, Cardiovascular and autoimmune diseases in females: The role of microvasculature and dysfunctional endothelium. Atherosclerosis 2015 241 259 263. doi: 10.1016/j.atherosclerosis.2015.03.044
81. Zhang J, Chen L, Delzell E, Muntner P, Hillegass WB, Safford MM, Millan IY, Crowson CS, Curtis JR, The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 2014 73 1301 1308. doi: 10.1136/annrheumdis-2013-204715
82. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL, Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001 44 2331 2337
83. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, D'Agostino RB, Kuller LH, Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997 145 408 415
84. Peters MJ, Symmons DP, McCarey D, EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010 69 325 331. doi: 10.1136/ard.2009.113696
85. Darby SC, Ewertz M, McGale P, Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013 368 987 998. doi: 10.1056/NEJMoa1209825
86. Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M, Evaluation and management of patients with heart disease and cancer: cardio-oncology. Mayo Clin Proc 2014 89 1287 1306. doi: 10.1016/j.mayocp.2014.05.013
87. Lancellotti P, Nkomo VT, Badano LP, European Society of Cardiology Working Groups on Nuclear Cardiology and Cardiac Computed Tomography and Cardiovascular Magnetic Resonance; American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography European Society of Cardiology Working Groups on Nuclear Cardiology and Cardiac Computed Tomography and Cardiovascular Magnetic Resonance; American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr 2013 26 1013 1032. doi: 10.1016/j.echo.2013.07.005
88. Musselman DL, Evans DL, Nemeroff CB, The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998 55 580 592
89. Shah AJ, Veledar E, Hong Y, Bremner JD, Vaccarino V, Depression and history of attempted suicide as risk factors for heart disease mortality in young individuals. Arch Gen Psychiatry 2011 68 1135 1142. doi: 10.1001/archgenpsychiatry.2011.125
90. Nabi H, Hall M, Koskenvuo M, Singh-Manoux A, Oksanen T, Suominen S, Kivimäki M, Vahtera J, Psychological and somatic symptoms of anxiety and risk of coronary heart disease: the health and social support prospective cohort study. Biol Psychiatry 2010 67 378 385. doi: 10.1016/j.biopsych.2009.07.040
91. Korkeila J, Vahtera J, Korkeila K, Kivimäki M, Sumanen M, Koskenvuo K, Koskenvuo M, Childhood adversities as predictors of incident coronary heart disease and cerebrovascular disease. Heart 2010 96 298 303. doi: 10.1136/hrt.2009.188250
92. Wyman L, Crum RM, Celentano D, Depressed mood and cause-specific mortality: a 40-year general community assessment. Ann Epidemiol 2012 22 638 643. doi: 10.1016/j.annepidem.2012.06.102
93. Ford ES, Capewell S, Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 2007 50 2128 2132. doi: 10.1016/j.jacc.2007.05.056
94. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PW, Wolf PA, Levy D, Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006 113 791 798. doi: 10.1161/CIRCULATIONAHA.105.548206
95. Kim ES, Carrigan TP, Menon V, Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion. J Am Coll Cardiol 2008 52 672 673. doi: 10.1016/j.jacc.2008.05.025
96. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE, Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005 62 593 602. doi: 10.1001/archpsyc.62.6.593
97. Mallik S, Spertus JA, Reid KJ, Krumholz HM, Rumsfeld JS, Weintraub WS, Agarwal P, Santra M, Bidyasar S, Lichtman JH, Wenger NK, Vaccarino V, PREMIER Registry Investigators PREMIER Registry Investigators Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch Intern Med 2006 166 876 883. doi: 10.1001/archinte.166.8.876
98. Champney KP, Frederick PD, Bueno H, Parashar S, Foody J, Merz CN, Canto JG, Lichtman JH, Vaccarino V, NRMI Investigators NRMI Investigators The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction. Heart 2009 95 895 899. doi: 10.1136/hrt.2008.155804
99. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH, Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med 1991 325 756 762. doi: 10.1056/NEJM199109123251102
100. Grodstein F, Stampfer M, The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995 38 199 210
101. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ, A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000 133 933 941
102. Wolf PH, Madans JH, Finucane FF, Higgins M, Kleinman JC, Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort. Am J Obstet Gynecol 1991 164 489 494
103. Henderson BE, Paganini-Hill A, Ross RK, Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991 151 75 78
104. Barrett-Connor E, Bush TL, Estrogen and coronary heart disease in women. JAMA 1991 265 1861 1867
105. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998 280 605 613
106. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women's Health Initiative Investigators Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002 288 321 333
107. Chandrasekar B, Nattel S, Tanguay JF, Coronary artery endothelial protection after local delivery of 17beta-estradiol during balloon angioplasty in a porcine model: a potential new pharmacologic approach to improve endothelial function. J Am Coll Cardiol 2001 38 1570 1576
108. Mori T, Durand J, Chen Y, Thompson JA, Bakir S, Oparil S, Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery. Am J Cardiol 2000 85 1276 1279
109. Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR, Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice R, Women's Health Initiative Investigators Women's Health Initiative Investigators Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 2006 166 357 365. doi: 10.1001/archinte.166.3.357
110. Salpeter SR, Walsh JM, Greyber E, Salpeter EE, Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J Gen Intern Med 2006 21 363 366. doi: 10.1111/j.1525-1497.2006.00389.x
111. Harman SM, Black DM, Naftolin F, Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med 2014 161 249 260. doi: 10.7326/M14-0353
112. Hodis HN, Mack WJ, Shoupe D, Azen SP, Stanczyk FZ, Hwang-Levine J, Budoff MJ, Henderson VW, Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis. Menopause 2015 22 391 401. doi: 10.1097/GME.0000000000000343
113. Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen RJ, Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2015 100 3975 4011. doi: 10.1210/jc.2015-2236
114. Kaunitz AM, Manson JE, Management of Menopausal Symptoms. Obstet Gynecol 2015 126 859 876. doi: 10.1097/AOG.0000000000001058
115. Chai X, Friebel TM, Singer CF, Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2014 148 397 406. doi: 10.1007/s10549-014-3134-0
116. Tuppurainen M, Kröger H, Honkanen R, Puntila E, Huopio J, Saarikoski S, Alhava E, Risks of perimenopausal fractures- A prospective population-based study. Acta Obstet Gynecol Scand 1995 74 624 628
117. Rivera CM, Grossardt BR, Rhodes DJ, Brown RD Jr, Roger VL, Melton LJ III, Rocca WA, Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009 16 15 23. doi: 10.1097/gme.0b013e31818888f7
118. Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, Shoupe D, Berek JS, Hankinson S, Manson JE, Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol 2009 113 1027 1037. doi: 10.1097/AOG.0b013e3181a11c64
119. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ III, Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007 69 1074 1083. doi: 10.1212/01.wnl.0000276984.19542.e6
120. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH, Menopause and the risk of coronary heart disease in women. N Engl J Med 1987 316 1105 1110. doi: 10.1056/NEJM198704303161801
121. Atsma F, Bartelink ML, Grobbee DE, Van der Schouw YT, Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006 13 265 279. doi: 10.1097/01.gme.0000218683.97338.ea
122. Mosca L, Benjamin EJ, Berra K, Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the american heart association. Circulation 2011 123 1243 1262. doi: 10.1161/CIR.0b013e31820faaf8
123. Hu FB, Stampfer MJ, Manson JE, Grodstein F, Colditz GA, Speizer FE, Willett WC, Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 2000 343 530 537. doi: 10.1056/NEJM200008243430802
124. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC, Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000 343 16 22. doi: 10.1056/NEJM200007063430103
125. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE, A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005 352 1293 1304. doi: 10.1056/NEJMoa050613
126. Final report on the aspirin component of the ongoing physicians' health study. Steering committee of the physicians' health study research group. N Engl J Med 1989 321 129 135
127. Simpson SH, Gamble JM, Mereu L, Chambers T, Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis. J Gen Intern Med 2011 26 1336 1344. doi: 10.1007/s11606-011-1757-y
128. Zhang C, Sun A, Zhang P, Wu C, Zhang S, Fu M, Wang K, Zou Y, Ge J, Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis. Diabetes Res Clin Pract 2010 87 211 218. doi: 10.1016/j.diabres.2009.09.029
129. Younis N, Williams S, Ammori B, Soran H, Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis. Expert Opin Pharmacother 2010 11 1459 1466. doi: 10.1517/14656561003792538
130. De Berardis G, Sacco M, Strippoli GF, Pellegrini F, Graziano G, Tognoni G, Nicolucci A, Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ 2009 339 b4531
131. Belch J, MacCuish A, Campbell I, Prevention of Progression of Arterial Disease and Diabetes Study Group; Diabetes Registry Group; Royal College of Physicians Edinburgh Prevention of Progression of Arterial Disease and Diabetes Study Group; Diabetes Registry Group; Royal College of Physicians Edinburgh The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008 337 a1840
132. Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Saito Y, Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA 2008 300 2134 2141. doi: 10.1001/jama.2008.623
133. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early treatment diabetic retinopathy study report 14. ETDRS investigators. JAMA 1992 268 1292 1300
134. Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS, American Diabetes Association; American Heart Association; American College of Cardiology Foundation American Diabetes Association; American Heart Association; American College of Cardiology Foundation Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care 2010 33 1395 1402. doi: 10.2337/dc10-0555
135. Walsh JM, Pignone M, Drug treatment of hyperlipidemia in women. JAMA 2004 291 2243 2252. doi: 10.1001/jama.291.18.2243
136. Abramson J, Wright JM, Are lipid-lowering guidelines evidence-based? Lancet 2007 369 168 169. doi: 10.1016/S0140-6736(07)60084-1
137. Fulcher J, O'Connell R, Voysey M, Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet 2015 385 1397 1405
138. Lopez-Jimenez F, Simha V, Thomas RJ, Allison TG, Basu A, Fernandes R, Hurst RT, Kopecky SL, Kullo IJ, Mulvagh SL, Thompson WG, Trejo-Gutierrez JF, Wright RS, A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps. Mayo Clin Proc 2014 89 1257 1278. doi: 10.1016/j.mayocp.2014.06.016
139. Mora S, Glynn RJ, Hsia J, MacFadyen JG, Genest J, Ridker PM, Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation 2010 121 1069 1077. doi: 10.1161/CIRCULATIONAHA.109.906479
140. Culver AL, Ockene IS, Balasubramanian R, Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med 2012 172 144 152. doi: 10.1001/archinternmed.2011.625
141. Sattar N, Preiss D, Murray HM, Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010 375 735 742. doi: 10.1016/S0140-6736(09)61965-6
142. Shaw LJ, Bugiardini R, Merz CN, Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol 2009 54 1561 1575. doi: 10.1016/j.jacc.2009.04.098
143. Brewer LC, Svatikova A, Mulvagh SL, The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in Women. Cardiovasc Drugs Ther 2015 29 355 368. doi: 10.1007/s10557-015-6607-4
144. Merz CN, The Yentl syndrome is alive and well. Eur Heart J 2011 32 1313 1315. doi: 10.1093/eurheartj/ehr083
145. Reis SE, Holubkov R, Conrad Smith AJ, Kelsey SF, Sharaf BL, Reichek N, Rogers WJ, Merz CN, Sopko G, Pepine CJ, WISE Investigators WISE Investigators Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J 2001 141 735 741
146. Agrawal S, Van Eyk J, Sobhani K, Wei J, Bairey Merz CN, Sex, Myocardial Infarction, and the Failure of Risk Scores in Women. J Womens Health (Larchmt) 2015 24 859 861. doi: 10.1089/jwh.2015.5412
147. Shah AS, Griffiths M, Lee KK, High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ 2015 350 g7873
148. Melander O, Maisel AS, Almgren P, Manjer J, Belting M, Hedblad B, Engström G, Kilger U, Nilsson P, Bergmann A, Orho-Melander M, Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality. JAMA 2012 308 1469 1475. doi: 10.1001/jama.2012.12998
149. Canto JG, Rogers WJ, Goldberg RJ, Peterson ED, Wenger NK, Vaccarino V, Kiefe CI, Frederick PD, Sopko G, Zheng ZJ, NRMI Investigators NRMI Investigators Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA 2012 307 813 822. doi: 10.1001/jama.2012.199
150. Mieres JH, Heller GV, Hendel RC, Gulati M, Boden WE, Katten D, Shaw LJ, Signs and symptoms of suspected myocardial ischemia in women: results from the What is the Optimal Method for Ischemia Evaluation in WomeN? Trial. J Womens Health (Larchmt) 2011 20 1261 1268. doi: 10.1089/jwh.2010.2595
151. Eastwood JA, Johnson BD, Rutledge T, Bittner V, Whittaker KS, Krantz DS, Cornell CE, Eteiba W, Handberg E, Vido D, Bairey Merz CN, Anginal symptoms, coronary artery disease, and adverse outcomes in Black and White women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. J Womens Health (Larchmt) 2013 22 724 732. doi: 10.1089/jwh.2012.4031
152. Bittencourt MS, Hulten E, Ghoshhajra B, Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging 2014 7 282 291. doi: 10.1161/CIRCIMAGING.113.001047
153. Gehrie ER, Reynolds HR, Chen AY, Neelon BH, Roe MT, Gibler WB, Ohman EM, Newby LK, Peterson ED, Hochman JS, Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J 2009 158 688 694. doi: 10.1016/j.ahj.2009.08.004
154. Beltrame JF, Assessing patients with myocardial infarction and nonobstructed coronary arteries (MINOCA). J Intern Med 2013 273 182 185. doi: 10.1111/j.1365-2796.2012.02591.x
155. Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF, Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation 2015 131 861 870. doi: 10.1161/CIRCULATIONAHA.114.011201
156. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM, Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999 341 217 225. doi: 10.1056/NEJM199907223410401
157. D'Onofrio G, Safdar B, Lichtman JH, Strait KM, Dreyer RP, Geda M, Spertus JA, Krumholz HM, Sex differences in reperfusion in young patients with ST-segment-elevation myocardial infarction: results from the VIRGO study. Circulation 2015 131 1324 1332. doi: 10.1161/CIRCULATIONAHA.114.012293
158. Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, Zineh I, Kelsey SF, Arnsdorf MF, Black HR, Pepine CJ, Merz CN, Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med 2009 169 843 850. doi: 10.1001/archinternmed.2009.50
159. Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, Johnson BD, Sopko G, Bairey Merz CN, Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 2010 55 2825 2832. doi: 10.1016/j.jacc.2010.01.054
160. Wei J, Mehta PK, Johnson BD, Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. JACC Cardiovasc Interv 2012 5 646 653. doi: 10.1016/j.jcin.2012.01.023
161. Herrmann J, Kaski JC, Lerman A, Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J 2012 33 2771 2782b. doi: 10.1093/eurheartj/ehs246
162. Rossi R, Nuzzo A, Origliani G, Modena MG, Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol 2008 51 997 1002. doi: 10.1016/j.jacc.2007.11.044
163. Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A, Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004 44 2137 2141. doi: 10.1016/j.jacc.2004.08.062
164. Sedlak TL, Lee M, Izadnegahdar M, Merz CN, Gao M, Humphries KH, Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease. Am Heart J 2013 166 38 44. doi: 10.1016/j.ahj.2013.03.015
165. Crea F, Camici PG, Bairey Merz CN, Coronary microvascular dysfunction: an update. Eur Heart J 2014 35 1101 1111. doi: 10.1093/eurheartj/eht513
166. Tweet MS, Hayes SN, Pitta SR, Simari RD, Lerman A, Lennon RJ, Gersh BJ, Khambatta S, Best PJ, Rihal CS, Gulati R, Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation 2012 126 579 588. doi: 10.1161/CIRCULATIONAHA.112.105718
167. Hayes SN, Spontaneous coronary artery dissection (SCAD): new insights into this not-so-rare condition. Tex Heart Inst J 2014 41 295 298. doi: 10.14503/THIJ-14-4089
168. Tweet MS, Gulati R, Aase LA, Hayes SN, Spontaneous coronary artery dissection: a disease-specific, social networking community-initiated study. Mayo Clin Proc 2011 86 845 850. doi: 10.4065/mcp.2011.0312
169. Goel K, Tweet M, Olson TM, Maleszewski JJ, Gulati R, Hayes SN, Familial spontaneous coronary artery dissection: evidence for genetic susceptibility. JAMA Intern Med 2015 175 821 826. doi: 10.1001/jamainternmed.2014.8307
170. Alfonso F, Paulo M, Lennie V, Dutary J, Bernardo E, Jiménez-Quevedo P, Gonzalo N, Escaned J, Bañuelos C, Pérez-Vizcayno MJ, Hernández R, Macaya C, Spontaneous coronary artery dissection: long-term follow-up of a large series of patients prospectively managed with a "conservative" therapeutic strategy. JACC Cardiovasc Interv 2012 5 1062 1070. doi: 10.1016/j.jcin.2012.06.014
171. Silber TC, Tweet MS, Bowman MJ, Hayes SN, Squires RW, Cardiac rehabilitation after spontaneous coronary artery dissection. J Cardiopulm Rehabil Prev 2015 35 328 333. doi: 10.1097/HCR.0000000000000111
172. Medeiros K, O'Connor MJ, Baicu CF, Fitzgibbons TP, Shaw P, Tighe DA, Zile MR, Aurigemma GP, Systolic and diastolic mechanics in stress cardiomyopathy. Circulation 2014 129 1659 1667. doi: 10.1161/CIRCULATIONAHA.113.002781
173. Templin C, Ghadri JR, Diekmann J, Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med 2015 373 929 938. doi: 10.1056/NEJMoa1406761
174. Citro R, Rigo F, D'Andrea A, Ciampi Q, Parodi G, Provenza G, Piccolo R, Mirra M, Zito C, Giudice R, Patella MM, Antonini-Canterin F, Bossone E, Piscione F, Salerno-Uriarte J, Tako-Tsubo Italian Network Investigators Tako-Tsubo Italian Network Investigators Echocardiographic correlates of acute heart failure, cardiogenic shock, and in-hospital mortality in tako-tsubo cardiomyopathy. JACC Cardiovasc Imaging 2014 7 119 129. doi: 10.1016/j.jcmg.2013.09.020
175. Previtali M, Repetto A, Camporotondo R, Clinical characteristics and outcome of left ventricular ballooning syndrome in a European population. Am J Cardiol 2011 107 120 125. doi: 10.1016/j.amjcard.2010.08.055
176. Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, Lesser JN, Haas TS, Hodges JS, Maron BJ, Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol 2010 55 333 341. doi: 10.1016/j.jacc.2009.08.057
177. Kyuma M, Tsuchihashi K, Shinshi Y, Hase M, Nakata T, Ooiwa H, Abiru M, Hikita N, Adachi T, Shoji T, Fujise Y, Shimamoto K, Effect of intravenous propranolol on left ventricular apical ballooning without coronary artery stenosis (ampulla cardiomyopathy): three cases. Circ J 2002 66 1181 1184
178. O'Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ, Fox KA, Lagerqvist B, McCullough PA, Murphy SA, Spacek R, Swahn E, Wallentin L, Windhausen F, Sabatine MS, Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA 2008 300 71 80. doi: 10.1001/jama.300.1.71
179. Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, Aylward P, Topol EJ, Califf RM, Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med 1999 341 226 232. doi: 10.1056/NEJM199907223410402
180. Rao SV, Hess CN, Barham B, A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. JACC Cardiovasc Interv 2014 7 857 867. doi: 10.1016/j.jcin.2014.04.007
181. Mieres JH, Gulati M, Bairey Merz N, Berman DS, Gerber TC, Hayes SN, Kramer CM, Min JK, Newby LK, Nixon JV, Srichai MB, Pellikka PA, Redberg RF, Wenger NK, Shaw LJ, American Heart Association Cardiac Imaging Committee of the Council on Clinical Cardiology; Cardiovascular Imaging and Intervention Committee of the Council on Cardiovascular Radiology and Intervention American Heart Association Cardiac Imaging Committee of the Council on Clinical Cardiology; Cardiovascular Imaging and Intervention Committee of the Council on Cardiovascular Radiology and Intervention Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association. Circulation 2014 130 350 379. doi: 10.1161/CIR.0000000000000061
182. Gibbons RJ, Balady GJ, Beasley JW, ACC/AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation 1997 96 345 354
183. Douglas PS, Hoffmann U, Patel MR, PROMISE Investigators PROMISE Investigators Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 2015 372 1291 1300. doi: 10.1056/NEJMoa1415516
184. Hoffmann U, Bamberg F, Chae CU, Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial. J Am Coll Cardiol 2009 53 1642 1650. doi: 10.1016/j.jacc.2009.01.052
185. Truong QA, Hayden D, Woodard PK, Kirby R, Chou ET, Nagurney JT, Wiviott SD, Fleg JL, Schoenfeld DA, Udelson JE, Hoffmann U, Sex differences in the effectiveness of early coronary computed tomographic angiography compared with standard emergency department evaluation for acute chest pain: the rule-out myocardial infarction with Computer-Assisted Tomography (ROMICAT)-II Trial. Circulation 2013 127 2494 2502. doi: 10.1161/CIRCULATIONAHA.113.001736
186. Borlaug BA, Paulus WJ, Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 2011 32 670 679. doi: 10.1093/eurheartj/ehq426
187. Paulus WJ, Tschöpe C, A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013 62 263 271. doi: 10.1016/j.jacc.2013.02.092
188. Borlaug BA, The pathophysiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 2014 11 507 515. doi: 10.1038/nrcardio.2014.83
189. Redfield MM, Chen HH, Borlaug BA, RELAX Trial RELAX Trial Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 2013 309 1268 1277. doi: 10.1001/jama.2013.2024
190. Yancy CW, Jessup M, Bozkurt B, American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013 62 e147 e239. doi: 10.1016/j.jacc.2013.05.019
191. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A, Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005 111 2050 2055. doi: 10.1161/01.CIR.0000162478.36652.7E
192. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010 12 767 778. doi: 10.1093/eurjhf/hfq120
193. Elkayam U, Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 2011 58 659 670. doi: 10.1016/j.jacc.2011.03.047
194. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011 32 3147 3197. doi: 10.1093/eurheartj/ehr218
195. McNamara DM, Elkayam U, Alharethi R, IPAC Investigators IPAC Investigators Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol 2015 66 905 914. doi: 10.1016/j.jacc.2015.06.1309
196. Tomasulo P, LactMed-new NLM database on drugs and lactation. Med Ref Serv Q 2007 26 51 58. doi: 10.1300/J115v26S01-04
197. Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, Rees K, Thompson DR, Taylor RS, Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2011 CD001800
198. Perk J, De Backer G, Gohlke H, Comitato per Linee Guida Pratiche (CPG) dell'ESC Comitato per Linee Guida Pratiche (CPG) dell'ESC [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)]. G Ital Cardiol (Rome) 2013 14 328 392. doi: 10.1714/1264.13964
199. Samayoa L, Grace SL, Gravely S, Scott LB, Marzolini S, Colella TJ, Sex differences in cardiac rehabilitation enrollment: a meta-analysis. Can J Cardiol 2014 30 793 800. doi: 10.1016/j.cjca.2013.11.007
200. McCarthy MM, Vaughan Dickson V, Chyun D, Barriers to cardiac rehabilitation in women with cardiovascular disease: an integrative review. J Cardiovasc Nurs 2011 26 E1 E10. doi: 10.1097/JCN.0b013e3181f877e9
201. Poli D, Antonucci E, Epidemiology, diagnosis, and management of atrial fibrillation in women. Int J Womens Health 2015 7 605 614. doi: 10.2147/IJWH.S45925
202. Emdin CA, Wong CX, Hsiao AJ, Altman DG, Peters SA, Woodward M, Odutayo AA, Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ 2016 532 h7013
203. Bushnell C, McCullough LD, Awad IA, American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council for High Blood Pressure Research American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council for High Blood Pressure Research Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014 45 1545 1588. doi: 10.1161/01.str.0000442009.06663.48
204. McDermott MM, Ferrucci L, Guralnik JM, Dyer AR, Liu K, Pearce WH, Clark E, Liao Y, Criqui MH, The ankle-brachial index is associated with the magnitude of impaired walking endurance among men and women with peripheral arterial disease. Vasc Med 2010 15 251 257. doi: 10.1177/1358863X10365181
205. McDermott MM, Greenland P, Liu K, Criqui MH, Guralnik JM, Celic L, Chan C, Sex differences in peripheral arterial disease: leg symptoms and physical functioning. J Am Geriatr Soc 2003 51 222 228
206. McDermott MM, Feinglass J, Slavensky R, Pearce WH, The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease. J Gen Intern Med 1994 9 445 449
207. Hirsch AT, Allison MA, Gomes AS, Corriere MA, Duval S, Ershow AG, Hiatt WR, Karas RH, Lovell MB, McDermott MM, Mendes DM, Nussmeier NA, Treat-Jacobson D, American Heart Association Council on Peripheral Vascular Disease; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology; Council on Epidemiology and Prevention American Heart Association Council on Peripheral Vascular Disease; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology; Council on Epidemiology and Prevention A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation 2012 125 1449 1472. doi: 10.1161/CIR.0b013e31824c39ba
208. McDermott MM, Fried L, Simonsick E, Ling S, Guralnik JM, Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study. Circulation 2000 101 1007 1012
209. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ, Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001 286 1599 1606
210. Aboyans V, Criqui MH, Abraham P, American Heart Association Council on Peripheral Vascular Disease; Council on Epidemiology and Prevention; Council on Clinical Cardiology; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia American Heart Association Council on Peripheral Vascular Disease; Council on Epidemiology and Prevention; Council on Clinical Cardiology; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 2012 126 2890 2909. doi: 10.1161/CIR.0b013e318276fbcb
211. Hirsch AT, Haskal ZJ, Hertzer NR, American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006 113 e463 e654. doi: 10.1161/CIRCULATIONAHA.106.174526
212. Scott RA, Wilson NM, Ashton HA, Kay DN, Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study. Br J Surg 1995 82 1066 1070
213. Lederle FA, Johnson GR, Wilson SE, Aneurysm Detection and Management Veterans Affairs Cooperative Study Aneurysm Detection and Management Veterans Affairs Cooperative Study Abdominal aortic aneurysm in women. J Vasc Surg 2001 34 122 126. doi: 10.1067/mva.2001.115275
214. McFarlane MJ, The epidemiologic necropsy for abdominal aortic aneurysm. JAMA 1991 265 2085 2088
215. US Preventive Services Task Force Screening for abdominal aortic aneurysm: Recommendation statement. Ann Intern Med 2005 142 198 202
216. Katz DJ, Stanley JC, Zelenock GB, Gender differences in abdominal aortic aneurysm prevalence, treatment, and outcome. J Vasc Surg 1997 25 561 568
217. Semmens JB, Norman PE, Lawrence-Brown MM, Holman CD, Influence of gender on outcome from ruptured abdominal aortic aneurysm. Br J Surg 2000 87 191 194. doi: 10.1046/j.1365-2168.2000.01346.x
218. Norman PE, Powell JT, Abdominal aortic aneurysm: the prognosis in women is worse than in men. Circulation 2007 115 2865 2869. doi: 10.1161/CIRCULATIONAHA.106.671859